Table 1.
Patient and tumor characteristics (all patients).
| Parameter | No. of patients (%) |
|---|---|
| Sex | |
|
| |
| Male | 11 (35%) |
| Female | 20 (65%) |
|
| |
| Age (range) | 56 (20–83) |
|
| |
| Race | |
|
| |
| Caucasian | 28 (90%) |
| African American | 3 (10%) |
|
| |
| History of tobacco use | 11 (35%) |
|
| |
| Family history of malignancy | 7 (23%) |
|
| |
| Breast cancer | 4 (13%) |
| Breast and ovarian cancers | 2 (6%) |
| Sarcoma | 1 (3%) |
|
| |
| Prior cancer | 4 (13%) |
|
| |
| Breast | 1 (3%) |
| Melanoma | 1 (3%) |
| Hodgkin's disease | 1 (3%) |
|
| |
| Prior radiation | 3 (10%) |
|
| |
| TNM stage | |
|
| |
| T2bN0M0 | 25 (81%) |
| T2bN0M1 | 4 (13%) |
| Desmoid | 2 (6%) |
|
| |
| Grade | |
|
| |
| 1 | 6 (19%) |
| 2 | 6 (19%) |
| 3 | 17 (55%) |
|
| |
| AJCC stage | |
|
| |
| I | 10 (32%) |
| III | 15 (48%) |
| IV | 4 (13%) |
|
| |
| Recurrent RPS | 7 (23%) |
|
| |
| Pretreatment size of RPS (range) | 10.5 cm (4.0–20.0) |
|
| |
| Histology | |
|
| |
| Leiomyosarcoma | 15 (48%) |
| Liposarcoma | 10 (32%) |
| Myxoid | 3 (10%) |
| Dedifferentiated | 4 (13%) |
| Desmoid | 2 (6%) |
| Malignant fibrous histiocytoma | 3 (10%) |
| Inflammatory myofibroblastic sarcoma | 1 (3%) |
|
| |
| CD 117 staining | |
|
| |
| Not done | 16 (52%) |
| Negative | 10 (32%) |
| Positive | 5 (16%) |
| Imatinib mesylate given | 1 (3%) |
|
| |
| Symptoms at presentation | |
|
| |
| Pain/discomfort | 20 (65%) |
| Weight loss (range) | 9 (31%) 10–30 lbs |
| Early satiety/decreased appetite | 6 (21%) |
| Nausea | 3 (10%) |
| Change in menses | 2 (7%) |
| Small bowel obstruction | 2 (7%) |